Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Glycine | HCID 750 | — |
| Reactant | Muscimol | HCID 4266 | — |
| Reactant | L-Glutamic Acid | HCID 33032 | — |
| Product | Glycine | HCID 750 | — |
| Product | L-glutamate(2-) | HCID 5460544 | — |
Reaction Steps
Dose-response displacement assays were conducted using 2-methyl carboxylate-5,7-dichloro-4-[[(diphenylamino)-carbonyl]amino]-quinoline and [3H]-TCP (both with and without added glycine), and [3 H]-muscimol. Displacement of [3H]-TCP binding was assayed in the presence of 10 uM L-glutamic acid and 3 uM glycine. This assay was conducted twice with triplicate samples and concentrations of test compound ranging from 1 uM to 5 nM. No significant effect on [3 H]-TCP binding was observed in this assay. Repetition of the TCP displacement experiment with L-glutamate but no added glycine gave similar results over a dose range of 5 uM to 10 nM. A synaptosomal competition binding assay was also conducted using 2-methyl carboxylate-5,7-dichloro-4-[[(diphenylamino)-carbonyl]amino]-quinoline and the ligand [3H]-muscimol. The purpose of this experiment was to check for activity at the GABA-A receptor complex. No significant effects were observed. The compound 2-methyl carboxylate-5,7-dichloro4-[[(diphenylamino)-carbonyl]amino]-quinoline also tested negative for PCP activity at the NMDA receptor, and for GABA-A effects.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05783700 |
|---|
| Source dataset | uspto-grants-1998_07 |
|---|
| ORD ID | ord-d1c66ed188584c409a2b3213fb4d6931 |
|---|
| Source note | uspto-grants-1998_07 |
|---|